Tyrosine Kinase Inhibitors: all 10,744 studies that test it
Page 96 of 108. Open to participants first (1,949), then studies with results posted, then the rest; newest registration first within each.
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerCompletedNCT00987766Phase 1
- Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC)SuspendedNCT00986284Phase 2
- The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid TumorsCompletedNCT00984425Phase 1
- Treatment of Patients With Nephrogenic Systemic Fibrosis With GlivecCompletedNCT00981942Phase 3
- Stereotactic Radiosurgery With Sunitinib for Brain MetastasesCompletedNCT00981890Phase 1
- A Study to Determine the Pharmacokinetics of Cediranib in Chinese Patients With Advanced Solid MalignanciesCompletedNCT00981721Phase 1
- Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine HydrochlorideCompletedNCT00981162Phase 1
- Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus SunitinibCompletedNCT00979966Phase 2
- Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent GlioblastomaCompletedNCT00979862Phase 1
- Pharmacokinetics (PK) Study of AC480 for Recurrent GliomaCompletedNCT00979173Phase 1
- Evaluation of Response of Dasatinib to Treat MastocytosisStatus unknownNCT00979160Phase 2
- Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)CompletedNCT00976170Phase 1
- Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's DiseaseCompletedNCT00976118Phase 2
- A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung CancerTerminatedNCT00975767Phase 1
- A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid TumorsCompletedNCT00975182Phase 1
- Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal SurgeryStatus unknownNCT00973869Phase 1
- A Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Short Term Exposure To PF-00299804TerminatedNCT00971191Phase 1
- Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)TerminatedNCT00971126Phase 1/2
- Study of KRN951 in Patients With Solid TumorsCompletedNCT00970411Phase 1
- Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric CancerCompletedNCT00970138Phase 2/3
- A Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic FunctionCompletedNCT00969813Phase 1
- Trial of Curcumin in Cutaneous T-cell Lymphoma PatientsWithdrawnNCT00969085Phase 2
- Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic CancerCompletedNCT00967603Phase 2
- Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain MetastasesCompletedNCT00967031Phase 2
- Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLCCompletedNCT00966472Phase 1
- Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00962312Phase 2
- Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With GlioblastomaCompletedNCT00960492Phase 1
- Phase I Study to Investigate Pharmacokinetics and Safety of BAY73-4506 in Asian (Japanese) Patients With Solid Tumors.CompletedNCT00960258Phase 1
- Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast CancerCompletedNCT00958971Phase 2
- Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)CompletedNCT00956436Phase 1
- Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT00955695Phase 3
- Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)CompletedNCT00955149Phase 1
- Maintenance Study on the Long Term Safety of XL999CompletedNCT00955084Phase 1
- Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung CancerCompletedNCT00954278Phase 1
- Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck CancerCompletedNCT00954226Phase 1
- Sunitinib Malate in Treating Patients With Small Cell Lung CancerTerminatedNCT00953459Phase 2
- Study Evaluating The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib In Healthy SubjectsCompletedNCT00952913Phase 1
- A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric CancerCompletedNCT00952497Phase 2
- CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid TumorsCompletedNCT00949624Phase 1
- A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the UrotheliumStatus unknownNCT00949455Phase 2/3
- Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00949182Phase 2
- Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 MutationsCompletedNCT00943943Phase 1
- Sunitinib Malate in Treating Patients With Kidney CancerCompletedNCT00943839Not applicable
- 4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT00943449Phase 2
- Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsCompletedNCT00942682Phase 1
- A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal TumorsCompletedNCT00940563Phase 2
- Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic LeukemiaCompletedNCT00940524Phase 1
- Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract CancersCompletedNCT00939848Phase 2/3
- Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerTerminatedNCT00937482Phase 1
- S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid TumorsWithdrawnNCT00937417Phase 1
- Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by SurgeryWithdrawnNCT00936832Phase 2
- Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)CompletedNCT00935987Phase 1/2
- Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRICompletedNCT00934882Phase 1
- Study Comparing Two Different Tablet Formulations Of BosutinibCompletedNCT00934674Phase 1
- Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung CancerWithdrawnNCT00934076Phase 1
- Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion ChemotherapyCompletedNCT00933816Phase 1/2
- Study Evaluating The Effect Of A High-Fat Meal On The Pharmacokinetics Of NeratinibWithdrawnNCT00932464Phase 1
- Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast CancerStatus unknownNCT00931450Phase 1/2
- Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell CarcinomaTerminatedNCT00930345Phase 4
- Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to TreatmentCompletedNCT00929903Phase 1
- Imatinib in Patients With Desmoid Tumor and ChondrosarcomaCompletedNCT00928525Phase 2
- A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical CarcinomaCompletedNCT00924989Phase 3
- Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic CancerCompletedNCT00922896Phase 2
- Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase InhibitorCompletedNCT00922584Phase 2
- A Study of E7050 Administered Orally to Patients With Advanced Solid TumorsCompletedNCT00921869Phase 1
- Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid TumorCompletedNCT00921336Phase 1
- XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + DasatinibCompletedNCT00920868Phase 1
- Safety Study of Foretinib (GSK1363089) in Adults With Liver CancerCompletedNCT00920192Phase 1
- Axitinib Pharmacokinetics in Chinese Healthy VolunteersCompletedNCT00919204Phase 1
- Food Effect Study Of AG-013736 In Healthy VolunteersCompletedNCT00918632Phase 1
- Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)CompletedNCT00914121Phase 1
- Masitinib in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid ArthritisCompletedNCT00913432Phase 2
- Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast CancerCompletedNCT00912275Phase 1/2
- PTC299 for Treatment of Neurofibromatosis Type 2TerminatedNCT00911248Phase 2
- Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCCCompletedNCT00908752Phase 3
- Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy RegimenStatus unknownNCT00908336Phase 2
- Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic MalignanciesCompletedNCT00908167Phase 1
- Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid TumorsTerminatedNCT00908024Phase 1/2
- Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00906360Phase 1
- A Bioequivalence Study Of AG-013736 Tablets In Healthy VolunteersCompletedNCT00905814Phase 1
- Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaTerminatedNCT00905398Phase 1/2
- Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological MalignanciesCompletedNCT00904787Phase 1
- Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive MeningiomaStatus unknownNCT00904735Phase 2
- An Explorative Study on the Pharmacokinetics and Pharmacodynamics of Sunitinib in Healthy VolunteersCompletedNCT00904657Phase 1
- An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation StatusCompletedNCT00903734Phase 1
- Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung AdenocarcinomaStatus unknownNCT00903292Not applicable
- Tarceva/Rapamycin for Children With Low-grade Gliomas With or Without Neurofibromatosis Type 1 (NF1)CompletedNCT00901849Phase 1
- Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in JapanCompletedNCT00898716Phase 1
- Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed GlioblastomaTerminatedNCT00895960Phase 1
- Study of Erlotinib in Combination With BortezomibCompletedNCT00895687Phase 1
- Erlotinib in Combination With CetuximabCompletedNCT00895362Phase 1
- Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid LeukemiaTerminatedNCT00895297Phase 2
- The Effects of Oral Curcumin on Heme Oxygenase-1 (HO-1) in Healthy Male SubjectsCompletedNCT00895167Phase 1
- Study of Erlotinib in Combination With DasatinibCompletedNCT00895128Phase 1
- Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid MalignanciesCompletedNCT00894894Phase 1
- Study Evaluating Sorafenib Added to Standard Primary Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Less Than 60 Years of AgeCompletedNCT00893373Phase 2
- Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP)CompletedNCT00892658Phase 1
- Sorafenib-RT Treatment for Liver Metastasis (SLIM)CompletedNCT00892424Phase 1/2
- Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic SyndromeCompletedNCT00892190Phase 1
- Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) MutationsCompletedNCT00891579Phase 2